GlassScriptPhysician profile
Mukul Mehra
NPI 1821053455
$193,184.40
in general payments reported to CMS, 2019-2025
18 companies · $79.86 in 2025
The $79.86 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112K · 2020: $35K · 2021: $21K · 2022: $25K · 2023: $1,367 · 2025: $79.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,350 · Food and Beverage: $96.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,350.00 |
| Food and Beverage | $96.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $129,733.72 | 2019-2023 | |
| Gilead Sciences, INC. | $57,372.23 | 2019-2025 | Livdelzi |
| Intercept Pharmaceuticals, INC. | $4,772.19 | 2019-2021 | |
| Janssen Biotech, INC. | $278.58 | 2019-2021 | |
| Romark Laboratories, Lc | $251.46 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $184.59 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.21 | 2019-2021 | |
| Pfizer INC. | $92.48 | 2019-2020 | |
| Braintree Laboratories, INC. | $85.19 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $69.90 | 2019 | |
| Qol Medical, LLC | $65.94 | 2019 | |
| Evoke Pharma, INC. | $38.61 | 2021-2023 | Gimoti |
| Shire North American Group INC | $34.05 | 2019 | |
| Daiichi Sankyo INC. | $32.53 | 2019 | |
| Ironwood Pharmaceuticals, INC | $30.60 | 2019-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mauna Kea Technologies, INC. | $13.47 | 2019 | |
| Nestle Healthcare Nutrition INC. | $12.37 | 2021 | |
| Shionogi INC | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mukul Mehra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.